Emerging applications of anticytokine vaccines

References

• Cohen S, Bigazzi PE, Yoshida T. Commentary. Similarities of T cell function in cell-mediated immunity and antibody production. Cell. Immunol.12(1), 150–159 (1974).
   PubMed Web of Science ®Google Scholar
• Oppenheim JJ, Feldmann M. Introduction to the role of cytokines in innate host defense and adaptive immunity. In: Cytokine Reference, Volume 1: Ligands. Oppenheim JJ, Feldmann M (Eds). Academic Press, London, UK 3–20 (2000).
   Google Scholar
• Baggiolini M. Reflections on chemokines. Immunol. Rev.177, 5–7 (2000).
   PubMed Web of Science ®Google Scholar
• Krause I, Valesini G, Scrivo R, Shoenfeld Y. Autoimmune aspects of cytokine and anticytokine therapies. Am. J. Med.115(5), 390–397 (2003).
   PubMed Web of Science ®Google Scholar
• Queen C, Schneider WP, Selick HE et al. A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl Acad. Sci. USA86(24), 10029–10033 (1989).
   PubMed Web of Science ®Google Scholar
• Chatenoud L. Monoclonal antibody-based strategies in autoimmunity and transplantation. Methods Mol. Med.109, 297–328 (2005).
   PubMedGoogle Scholar
• Zagury D, Le Buanec H, Bizzini B, Burny A, Lewis G, Gallo RC. Active versus passive anticytokine antibody therapy against cytokine-associated chronic diseases. Cytokine Growth Factor Rev.14(2), 123–137 (2003).
   PubMed Web of Science ®Google Scholar
• Watanabe M, Uchida K, Nakagaki K et al. Anticytokine autoantibodies are ubiquitous in healthy individuals. FEBS Lett.581(10), 2017–2021 (2007).
   PubMed Web of Science ®Google Scholar
• Bachmann MF, Dyer MR. Therapeutic vaccination for chronic diseases: a new class of drugs in sight. Nat. Rev. Drug Discov.3(1), 81–88 (2004).
   PubMed Web of Science ®Google Scholar
• Tissot AC, Maurer P, Nussberger J et al. Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled Phase IIa study. Lancet371(9615), 821–827 (2008).
   PubMed Web of Science ®Google Scholar
• Delavallee L, Assier E, Denys A et al. Vaccination with cytokines in autoimmune diseases. Ann. Med.40(5), 343–351 (2008).
   PubMed Web of Science ®Google Scholar
• Dalum I, Butler DM, Jensen MR et al. Therapeutic antibodies elicited by immunization against TNF-α. Nat. Biotechnol.17(7), 666–669 (1999).
   PubMed Web of Science ®Google Scholar
• Tan GH, Wang CC, Huang FY, Wang H, Huang YH, Lin YY. Active immunotherapy of allergic asthma with a recombinant human interleukin-5 protein as vaccine in a murine model. Chin. Med. J. (Engl.)120(17), 1517–1522 (2007).
   PubMed Web of Science ®Google Scholar
• Rohn TA, Jennings GT, Hernandez M et al. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur. J. Immunol.36(11), 2857–2867 (2006).
   PubMed Web of Science ®Google Scholar
• Delavallee L, Le Buanec H, Bessis N et al. Early and long-lasting protection from arthritis in tumour necrosis factor α (TNFα) transgenic mice vaccinated against TNFα. Ann. Rheum. Dis.67(9), 1332–1338 (2008).
   PubMed Web of Science ®Google Scholar
• Le Buanec H, Paturance S, Couillin I et al. Control of allergic reactions in mice by an active anti-murine IL-4 immunization. Vaccine25(41), 7206–7216 (2007).
   PubMed Web of Science ®Google Scholar
• Uyttenhove C, Van Snick J. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur. J. Immunol.36(11), 2868–2874 (2006).
   PubMed Web of Science ®Google Scholar
• Uyttenhove C, Arendse B, Stroobant V, Brombacher F, Van Snick J. Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection. Eur. J. Immunol.34(12), 3572–3581 (2004).
   PubMed Web of Science ®Google Scholar
• Tighe H, Corr M, Roman M, Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today19(2), 89–97 (1998).
   PubMedGoogle Scholar
• Shen Y, Chen J, Zhang X, Wu X, Xu Q. Human TNF-α gene vaccination prevents collagen-induced arthritis in mice. Int. Immunopharmacol.7(9), 1140–1149 (2007).
   PubMed Web of Science ®Google Scholar
• Youssef S, Wildbaum G, Maor G et al. Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines. J. Immunol.161(8), 3870–3879 (1998).
   PubMed Web of Science ®Google Scholar
• He X, Tsang TC, Zhang T, Luo P, Harris DT. Antigen epitope-expressing cytokines for DNA immunization. Vaccine23(16), 1966–1972 (2005).
   PubMed Web of Science ®Google Scholar
• Falgarone G, Duclos M, Boissier MC. TNFα antagonists in rheumatoid arthritis patients seen in everyday practice. Joint Bone Spine74(6), 523–526 (2007).
   PubMed Web of Science ®Google Scholar
• Boissier MC, Assier E, Falgarone G, Bessis N. Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine74(4), 373–375 (2008).
   Web of Science ®Google Scholar
• Keffer J, Probert L, Cazlaris H et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J.10(13), 4025–4031 (1991).
   PubMed Web of Science ®Google Scholar
• Bloquel C, Denys A, Boissier MC et al. Intra-articular electrotransfer of plasmid encoding soluble TNF receptor variants in normal and arthritic mice. J. Gene Med.9(11), 986–993 (2007).
   PubMed Web of Science ®Google Scholar
• Wildbaum G, Youssef S, Karin N. A targeted DNA vaccine augments the natural immune response to self TNF-α and suppresses ongoing adjuvant arthritis. J. Immunol.165(10), 5860–5866 (2000).
   PubMed Web of Science ®Google Scholar
• Chackerian B, Lowy DR, Schiller JT. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J. Clin. Invest.108(3), 415–423 (2001).
   PubMed Web of Science ®Google Scholar
• Spohn G, Guler R, Johansen P et al. A virus-like particle-based vaccine selectively targeting soluble TNF-α protects from arthritis without inducing reactivation of latent tuberculosis. J. Immunol.178(11), 7450–7457 (2007).
   PubMed Web of Science ®Google Scholar
• Bizzini B, Achour A. “Kinoids”: the basis for anticytokine immunization and their use in HIV infection. Cell. Mol. Biol. (Noisy-le-Grand)41(3), 351–356 (1995).
   PubMed Web of Science ®Google Scholar
• Le Buanec H, Delavallee L, Bessis N et al. TNFα kinoid vaccination-induced neutralizing antibodies to TNFα protect mice from autologous TNFα-driven chronic and acute inflammation. Proc. Natl Acad. Sci. USA, 103(51), 19442–19447 (2006).
   PubMed Web of Science ®Google Scholar
• Spohn G, Keller I, Beck M, Grest P, Jennings GT, Bachmann MF. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis. Eur. J. Immunol.38(3), 877–887 (2008).
   PubMed Web of Science ®Google Scholar
• Bertin-Maghit SM, Capini CJ et al. Improvement of collagen-induced arthritis by active immunization against murine IL-1β peptides designed by molecular modelling. Vaccine23(33), 4228–4235 (2005).
   PubMed Web of Science ®Google Scholar
• Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther.7(1), 29–37 (2005).
   PubMed Web of Science ®Google Scholar
• Galle P, Jensen L, Andersson C et al. Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation. Int. Immunopharmacol.7(13), 1704–1713 (2007).
   PubMed Web of Science ®Google Scholar
• Onodera S, Ohshima S, Tohyama H et al. A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis. Arthritis Rheum.56(2), 521–530 (2007).
   PubMed Web of Science ®Google Scholar
• Goldberg R, Wildbaum G, Zohar Y, Maor G, Karin N. Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J. Immunol.173(2), 1171–1178 (2004).
   PubMed Web of Science ®Google Scholar
• Barnes DA, Tse J, Kaufhold M et al. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J. Clin. Invest.101(12), 2910–2919 (1998).
   PubMed Web of Science ®Google Scholar
• Youssef S, Maor G, Wildbaum G, Grabie N, Gour-Lavie A, Karin N. C–C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. J. Clin. Invest.106(3), 361–371 (2000).
   PubMed Web of Science ®Google Scholar
• Goldberg R, Zohar Y, Wildbaum G, Geron Y, Maor G, Karin N. Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27. J. Immunol.173(10), 6465–6471 (2004).
   PubMed Web of Science ®Google Scholar
• Wildbaum G, Karin N. Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-α) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis. Gene Ther.6(6), 1128–1138 (1999).
   PubMed Web of Science ®Google Scholar
• Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD. An important role for the chemokine macrophage inflammatory protein-1 α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol.155(10), 5003–5010 (1995).
   PubMed Web of Science ®Google Scholar
• Youssef S, Wildbaum G, Karin N. Prevention of experimental autoimmune encephalomyelitis by MIP-1α and MCP-1 naked DNA vaccines. J. Autoimmun.13(1), 21–29 (1999).
   PubMed Web of Science ®Google Scholar
• Nabors GS, Farrell JP. Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses. Infect. Immun.62(12), 5498–5504 (1994).
   PubMed Web of Science ®Google Scholar
• Yang G, Li L, Volk A et al. Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice. J. Pharmacol. Exp. Ther.313(1), 8–15 (2005).
   PubMed Web of Science ®Google Scholar
• Yang J, Torio A, Donoff RB et al. Depletion of eosinophil infiltration by anti-IL-5 monoclonal antibody (TRFK-5) accelerates open skin wound epithelial closure. Am. J. Pathol.151(3), 813–819 (1997).
   PubMed Web of Science ®Google Scholar
• Hertz M, Mahalingam S, Dalum I et al. Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma. J. Immunol.167(7), 3792–3799 (2001).
   PubMed Web of Science ®Google Scholar
• Tan GH, Su JM, Wang CC et al. A recombinant DNA plasmid encoding the human interleukin-5 breaks immunological tolerance and inhibits airway inflammation in a murine model of asthma. Int. Arch. Allergy Immunol.145(4), 313–323 (2008).
   PubMed Web of Science ®Google Scholar
• Zuany-Amorim C, Manlius C, Dalum I et al. Induction of TNF-α autoantibody production by AutoVac TNF106: a novel therapeutic approach for the treatment of allergic diseases. Int. Arch. Allergy Immunol.133(2), 154–163 (2004).
   PubMed Web of Science ®Google Scholar
• Ma Y, Ma AG, Peng Z. A potential immunotherapy approach: mucosal immunization with an IL-13 peptide-based virus-like particle vaccine in a mouse asthma model. Vaccine25(47), 8091–8099 (2007).
   PubMed Web of Science ®Google Scholar
• Bossu P, Neumann D, Del Giudice E et al. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc. Natl Acad. Sci. USA100(24), 14181–14186 (2003).
   PubMed Web of Science ®Google Scholar
• Hauer AD, Uyttenhove C, de Vos P et al. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation112(7), 1054–1062 (2005).
   PubMed Web of Science ®Google Scholar
• Sonderegger I, Rohn TA, Kurrer MO et al. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur. J. Immunol.36(11), 2849–2856 (2006).
   PubMed Web of Science ®Google Scholar
• Delmas PD. Clinical potential of RANKL Inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases. J. Clin. Densitom.11(2), 325–338 (2008).
   PubMed Web of Science ®Google Scholar
• Spohn G, Schwarz K, Maurer P, Illges H et al. Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles. J. Immunol.175(9), 6211–6218 (2005).
   PubMed Web of Science ®Google Scholar
• Richard M, Grencis RK, Humphreys NE, Renauld JC, Van Snick J. Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc. Natl Acad. Sci. USA97(2), 767–772 (2000).
   PubMed Web of Science ®Google Scholar
• Bizzini B, Volpato I, Lachgar A, Cohen P, Gringeri A. IFN α kinoid vaccine in conjunction with tritherapy, a weapon to combat immunopathogenesis in AIDS. Biomed. Pharmacother.53(2), 87–89 (1999).
   PubMed Web of Science ®Google Scholar
• Carelli C, Halbreich A, Bernard J et al. Immunogenicity of combined anti-HIV and anti-suppressive vaccine preparations. Biomed. Pharmacother.46(4), 149–153 (1992).
   PubMed Web of Science ®Google Scholar
• Gringeri A, Musicco M, Hermans P et al. Active anti-interferon-α immunization: a European–Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (the EURIS study). J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.20(4), 358–370 (1999).
   PubMedGoogle Scholar
• Salazar-Onfray F, Lopez MN, Mendoza-Naranjo A. Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev.18(1–2), 171–182 (2007).
   PubMed Web of Science ®Google Scholar
• Rad FH, Le Buanec H, Paturance S et al. VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases. Proc. Natl Acad. Sci. USA104(8), 2837–2842 (2007).
   PubMed Web of Science ®Google Scholar
• Bequet-Romero M, Ayala M, Acevedo BE et al. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice. Angiogenesis10(1), 23–34 (2007).
   PubMedGoogle Scholar
• Casaco A, Diaz Y, Ledon N et al. Effect of an EGF-cancer vaccine on wound healing and inflammation models. J. Surg. Res.122(1), 130–134 (2004).
   PubMed Web of Science ®Google Scholar
• Neninger Vinageras E, de la Torre A, Osorio Rodriguez M et al. Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer. J. Clin. Oncol.26(9), 1452–1458 (2008).
   PubMed Web of Science ®Google Scholar
• Waterston AM, Salway F, Andreakos E, Butler DM, Feldmann M, Coombes RC. TNF autovaccination induces self anti-TNF antibodies and inhibits metastasis in a murine melanoma model. Br. J. Cancer90(6), 1279–1284 (2004).
   PubMed Web of Science ®Google Scholar
• Waterston AM, Gumbrell L, Bratt T et al. Phase I study of TNFα autovaccine in patients with metastatic cancer. Cancer Immunol. Immunother.54(9), 848–857 (2005).
   PubMed Web of Science ®Google Scholar
• Zagury D, Gallo RC. Anticytokine Ab immune therapy: present status and perspectives. Drug Discov. Today9(2), 72–81 (2004).
   PubMed Web of Science ®Google Scholar
• Ferrer I, Boada Rovira M, Sanchez Guerra ML, Rey MJ, Costa-Jussa F. Neuropathology and pathogenesis of encephalitis following amyloid-β immunization in Alzheimer’s disease. Brain Pathol.14(1), 11–20 (2004).
   PubMed Web of Science ®Google Scholar
• Ma X, Chow JM, Gri G, Carra G et al. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med.183(1), 147–157. (1996).
   PubMed Web of Science ®Google Scholar
• Niethammer AG, Xiang R, Becker JC et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat. Med.8(12), 1369–1375 (2002).
   PubMed Web of Science ®Google Scholar
• Onodera M, Nelson DM, Sakiyama Y, Candotti F, Blaese RM. Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials. Acta Haematol.101(2), 89–96 (1999).
   PubMed Web of Science ®Google Scholar
• Capini CJ, Bertin-Maghit SM, Bessis N et al. Active immunization against murine TNFα peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection. Vaccine22(23–24), 3144–3153 (2004).
   PubMed Web of Science ®Google Scholar